the importance of diagnosing and treating oligometastatic prostate cancer and adt usage
Published 2 weeks ago • 57 plays • Length 8:36Download video MP4
Download video MP3
Similar videos
-
22:00
debate: prostate cancer patients should/should not get chemo and adt as a standard of care
-
16:50
treatment of oligometastatic disease
-
18:18
management of the primary in locally advanced and oligometastatic disease
-
18:55
debate: how should we manage oligometastatic disease?
-
15:56
radiation oncology advances in precision diagnosis and treatment for prostate cancer
-
17:59
what is oligometastatic prostate cancer?
-
17:38
androgen deprivation therapy (adt) and cognitive health
-
57:05
can radiotherapy cure stage iv cancer? the future of oligometastatic cancer
-
14:36
new considerations for oligometastatic prostate cancer
-
27:05
adt for prostate cancer: agonists vs antagonists
-
8:26
combination of prostate ablation with systemic therapy for management of prostate cancer
-
15:37
choosing systemic therapy for men with metastatic hormone sensitive prostate cancer
-
0:49
unmet needs for radiotherapy in metastatic and oligometastatic prostate cancer
-
10:38
updates in treatment using adt and anti-androgens
-
1:11:08
the role of parp inhibitors in advanced prostate cancer
-
2:40
oligometastatic prostate cancer and the importance of the radiation oncologist in its management
-
5:18
overview of oligometastatic prostate cancer (basic royal) | prostate cancer staging guide
-
18:07
radical prostatectomy for oligometastatic prostate cancer
-
19:56
recognizing and managing side effects of androgen deprivation therapy (adt)
-
1:43
defining and classifying oligometastatic prostate cancer
-
6:53
perspectives on metastatic hormone-sensitive prostate cancer | bayer